321 related articles for article (PubMed ID: 22713668)
1. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.
Wang C; Zheng X; Shen C; Shi Y
J Exp Clin Cancer Res; 2012 Jun; 31(1):58. PubMed ID: 22713668
[TBL] [Abstract][Full Text] [Related]
2. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
Sui Y; Zhang X; Yang H; Wei W; Wang M
Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
6. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
[TBL] [Abstract][Full Text] [Related]
7. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells.
Li H; Xiang Z; Liu Y; Xu B; Tang J
Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
[TBL] [Abstract][Full Text] [Related]
10. CircRNA SEPT9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1.
Yue L; Wang G; Zhu M
Brain Res; 2021 Sep; 1766():147501. PubMed ID: 33915163
[TBL] [Abstract][Full Text] [Related]
11. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
Hu S; Ran Y; Chen W; Zhang Y; Xu Y
Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1.
Tan J; Jing YY; Han L; Zheng HW; Shen JX; Zhang LH; Yu LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6350-6357. PubMed ID: 30338803
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract][Full Text] [Related]
15. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.
Takeshita N; Mori M; Kano M; Hoshino I; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Miyazawa Y; Matsubara H
Int J Oncol; 2012 Nov; 41(5):1653-61. PubMed ID: 22940702
[TBL] [Abstract][Full Text] [Related]
16. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
17. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
18. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
[TBL] [Abstract][Full Text] [Related]
19. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
20. LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1.
Shen Q; Sun Y; Xu S
Respir Res; 2020 Sep; 21(1):235. PubMed ID: 32938459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]